Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

2677

Actual shortage: 255 (10%)
Anticipated shortage: 0 (0%)
Avoided shortage: 9 (0%)
Resolved: 2413 (90%)

Discontinuation Reports

250

To be discontinued: 3 (1%)
Discontinued: 247 (99%)
Reversed: 0 (0%)

Late reports

330 (11%)

Overdue reports

30 (12%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
NOVAMOXIN 500MG CAPSULE Resolved 2023-06-20 2023-07-05 195818
NOVAMOXIN 250MG GRANULES FOR SUSPENSION Actual shortage 2023-10-19 2024-03-18 207503
NOVASEN 325MG TABLET (DELAYED-RELEASE) Resolved 2017-04-03 2017-05-23 5165
TEVA-CYPROTERONE / ETHINYL ESTRADIOL 0.035MG 2MG TABLET Resolved 2017-04-25 2017-09-19 8068
NOVO-GESIC 325MG TABLET Resolved 2019-06-27 2020-03-19 87680
NOVO-GESIC 325MG TABLET Resolved 2020-03-26 2020-05-21 109571
NOVO-GESIC 325MG TABLET Resolved 2022-08-18 2022-09-23 167229
NOVO-GESIC FORTE 500MG TABLET Resolved 2020-04-10 2020-06-04 111829
NOVO-HYDROXYZIN 10MG CAPSULE Actual shortage 2017-03-10 2017-10-05 159
NOVO-HYDROXYZIN 25MG CAPSULE Actual shortage 2017-03-13 2017-10-05 1013
NOVO-HYDROXYZIN 50MG CAPSULE Actual shortage 2017-03-13 2020-02-13 1017
TEVA-MYCOPHENOLATE 250MG CAPSULE Resolved 2017-03-14 2017-04-25 2278
NOVO-PROFEN 400MG TABLET Resolved 2018-03-13 2018-05-30 42644
NV-CLINDAMYCIN 150MG CAPSULE Resolved 2020-09-24 2020-10-08 124959
NV-CLINDAMYCIN 150MG CAPSULE Resolved 2021-03-11 2021-04-29 135561
OCTREOTIDE FOR INJECTABLE SUSPENSION 10MG POWDER FOR SUSPENSION, EXTENDED-RELEASE KIT Resolved 2022-03-04 2022-03-24 156070
OCTREOTIDE FOR INJECTABLE SUSPENSION 10MG POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT Actual shortage 2022-08-18 2024-04-29 166969
OCTREOTIDE FOR INJECTABLE SUSPENSION 20MG POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT Actual shortage 2022-08-18 2024-04-29 166972
OCTREOTIDE FOR INJECTABLE SUSPENSION 30MG POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT Actual shortage 2022-08-18 2024-04-29 166975
ONDANSETRON INJECTION 2MG SOLUTION Actual shortage 2017-03-13 2017-10-05 1746

Showing 461 to 480 of 2677

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
EPIRUBICIN FOR INJECTION 2MG SOLUTION Discontinued 2020-10-22 2020-10-24 126906
EPTIFIBATIDE INJECTION 0.75MG SOLUTION Discontinued 2017-06-27 2017-06-27 14024
EPTIFIBATIDE INJECTION 2MG SOLUTION Discontinued 2017-06-27 2017-06-27 14027
EPTIFIBATIDE INJECTION Discontinued 2020-02-13 2020-02-13 106170
EPTIFIBATIDE INJECTION Discontinued 2020-02-13 2020-02-13 106176
GEMCITABINE FOR INJECTION 1G POWDER FOR SOLUTION Discontinued 2017-06-27 2017-06-27 14033
GEMCITABINE FOR INJECTION Discontinued 2018-10-12 2018-10-12 63967
GEMCITABINE FOR INJECTION Discontinued 2018-10-12 2018-10-12 63970
GEMCITABINE FOR INJECTION Discontinued 2020-02-13 2020-02-13 106155
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81330
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81337
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81344
HYDROCORTISONE SODIUM SUCCINATE INJECTION Discontinued 2019-04-11 2019-04-11 81347
LEUCOVORIN CALCIUM INJECTION 10MG SOLUTION Discontinued 2017-06-27 2017-06-27 14036
LINEZOLID INJECTION Discontinued 2020-02-13 2020-02-13 106173
METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION 40MG POWDER FOR SOLUTION Discontinued 2021-09-23 2021-09-23 146061
NOVAMOXIN 500MG CAPSULE Discontinued 2017-06-27 2017-06-27 14046
NOVAMOXIN 250MG GRANULES FOR SUSPENSION Discontinued 2019-04-11 2019-04-11 81316
NOVAMOXIN 125MG TABLET (CHEWABLE) Discontinued 2019-04-11 2019-04-11 81321
NOVAMOXIN 25MG GRANULES FOR SUSPENSION Discontinued 2019-04-11 2019-04-11 81393

Showing 61 to 80 of 250